Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totaling 46,134 shares, a decrease of 46.0% from the July 15th total of 85,412 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 251,156 shares, the short-interest ratio is presently 0.2 days.

Terumo Stock Down 1.4%

OTCMKTS TRUMY traded down $0.23 during trading on Monday, hitting $16.43. The stock had a trading volume of 26,048 shares, compared to its average volume of 279,280. Terumo has a 12 month low of $12.08 and a 12 month high of $19.60. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59. The company’s 50-day moving average price is $14.21 and its two-hundred day moving average price is $13.65. The company has a market capitalization of $24.24 billion, a PE ratio of 23.15 and a beta of 0.68.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings results on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.55%. The company had revenue of $1.97 billion during the quarter, compared to analysts’ expectations of $1.84 billion. As a group, sell-side analysts forecast that Terumo will post 0.7 EPS for the current year.

Analysts Set New Price Targets

Separately, Nomura upgraded Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.